Joel E. Schlosburg, PhD

Affiliations: 
Committee on the Neurobiology of Addictive Disorders Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Area:
Endocannabinoids, drug abuse, opiate self-administration
Google:
"Joel Schlosburg"
Mean distance: 14.06 (cluster 19)
 
SNBCP

Parents

Sign in to add mentor
Larry Reid research assistant 2004-2005 RPI
 (Undergraduate, estradiol effects on palatable food intake)
Aron H. Lichtman grad student 2005-2010 VCU
 (Differential roles of the two major endocannabinoid hydrolyzing enzymes in cannabinoid receptor tolerance and somatic withdrawal.)
George F. Koob post-doc 2011- Scripps Institute
Kim David Janda post-doc 2012- Scripps Institute (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mustafa MA, Poklis JL, Karin KN, et al. (2023) Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm. Cannabis and Cannabinoid Research
Dodu JC, Moncayo RK, Damaj MI, et al. (2021) The CB Receptor Positive Allosteric Modulator, ZCZ011, Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice. The Journal of Pharmacology and Experimental Therapeutics
McGinn MA, Tunstall BJ, Schlosburg JE, et al. (2021) Glucocorticoid receptor modulators decrease alcohol self-administration in male rats. Neuropharmacology. 108510
Muldoon PP, Akinola LS, Schlosburg JE, et al. (2020) Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice. Neuropharmacology. 108170
Serrano A, Pavon FJ, Buczynski MW, et al. (2018) Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Bremer PT, Schlosburg JE, Banks ML, et al. (2017) Development of a Clinically-Viable Heroin Vaccine. Journal of the American Chemical Society
Collins KC, Schlosburg JE, Bremer PT, et al. (2016) Methamphetamine Vaccines: Improvement through Hapten Design. Journal of Medicinal Chemistry
Jacob NT, Lockner JW, Schlosburg JE, et al. (2016) Investigations of Enantiopure Nicotine Haptens using an Adjuvanting Carrier in Anti-Nicotine Vaccine Development. Journal of Medicinal Chemistry
Bremer PT, Kimishima A, Schlosburg JE, et al. (2016) Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs. Angewandte Chemie (International Ed. in English)
Xue S, Schlosburg JE, Janda KD. (2015) A New Strategy for Smoking Cessation: Characterization of a Bacterial Enzyme for the Degradation of Nicotine. Journal of the American Chemical Society. 137: 10136-9
See more...